AR012732A1 - Derivados de fenilquinolinas, procedimientos para su preparacion, composiciones farmaceuticas, y su uso para la fabricacion de medicamentos - Google Patents
Derivados de fenilquinolinas, procedimientos para su preparacion, composiciones farmaceuticas, y su uso para la fabricacion de medicamentosInfo
- Publication number
- AR012732A1 AR012732A1 ARP980102363A ARP980102363A AR012732A1 AR 012732 A1 AR012732 A1 AR 012732A1 AR P980102363 A ARP980102363 A AR P980102363A AR P980102363 A ARP980102363 A AR P980102363A AR 012732 A1 AR012732 A1 AR 012732A1
- Authority
- AR
- Argentina
- Prior art keywords
- 6alkyl
- alkyl
- group
- optionally substituted
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Derivados de fenilquinolinas o un solvato o una sal de formula (I) en la que Ar es un grupo arilo o cicloalcadienilo C5-7 opcionalmente sustituido, o ungrupo cicloalquilo C5-7 o un grupo hetercíclico aromático de anillo unico o condensado opcionalmente sustituido; R es alquilo C1-6, cicloalquilo C3-7,cicloalquil C3-7-alquilo, fenilo o fenil-alquilo C1-6 opcionalmente sustituido un anillo heteroaromático de cinco miembros, opcionalmente sustituido, quecomprende hasta 4 heteroátomos seleccionados ente O y N, hidroxi-alquilo C1-6, amino-alquilo C1-6, alquil C1-6-aminoalquilo, di-alquil C1-6-aminoalquilo, acilC1-6-aminoalquilo, alcoxi C1-6-alquilo, alquil C1-6-carbonilo, carboxi, alcoxi C1-6-carbonilo, alcoxi C1-6-carbonil-alquilo C1-6, aminocarbonilo,alquil C1-6-aminocarbonilo, di-alquil C1-6-aminocarbonio, halogeno-alquilo C1-6; o R es un grupo -(CH2)p-en que p es 2 o 3, cuyo grupo forma un anillo con un átomos decarbono de Ar; R1 representa hidrogeno o hasta cuatro sustituyentes opcionales seleccionados entre la lista que consta de: alquilo C1-6, alquenilo C1-6, ariloalcoxi C1-6, hidroxi, halogeno, nitro ciano, carboxi, carboxamido, sulfonamido, alcoxi C1-6-carbonilo, trifluorometilo, aciloxi, ftalmido, amino o mono- ydi-alquil C1-6-amino; R2 representa un resto -(CH2)n-NY1Y2 en que n es un numero entero en el margen de 1 a 9, Y1 e Y2 se seleccionan independientemente entrehidrogeno, alquilo C1-6; alqluilo C1-6 sustituido con hidroxi, alquil C1-6 amino obis (alquil C1-6)-amino; alquenilo C1-6; arilo o aril-alquilo C1-6, oY1 e Y2 conjuntamente con el átomo de nitrogeno al que están unidos, representan un grupo heterecíclico simple o condensado enlazado en N yopcionalmente sustituido; R3 esalquilo C1-6 ramificado o lineal, cicloalquilo C3-7, cicloalquilo C4-7, arilo opcionalmente sustituido, o un grupo
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9710750.2A GB9710750D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
| IT002354 IT1295358B1 (it) | 1997-10-17 | 1997-10-17 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
| ITMI972775 IT1296976B1 (it) | 1997-12-16 | 1997-12-16 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012732A1 true AR012732A1 (es) | 2000-11-08 |
Family
ID=27268859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102363A AR012732A1 (es) | 1997-05-23 | 1998-05-21 | Derivados de fenilquinolinas, procedimientos para su preparacion, composiciones farmaceuticas, y su uso para la fabricacion de medicamentos |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0983262B1 (es) |
| JP (1) | JP2002500645A (es) |
| CN (1) | CN1264378A (es) |
| AP (1) | AP9901695A0 (es) |
| AR (1) | AR012732A1 (es) |
| AT (1) | ATE244711T1 (es) |
| AU (1) | AU8209898A (es) |
| BG (1) | BG104009A (es) |
| BR (1) | BR9809652A (es) |
| CA (1) | CA2291111A1 (es) |
| CO (1) | CO4950515A1 (es) |
| DE (1) | DE69816290T2 (es) |
| DZ (1) | DZ2498A1 (es) |
| EA (1) | EA199901062A1 (es) |
| ES (1) | ES2201509T3 (es) |
| HU (1) | HUP0002300A3 (es) |
| ID (1) | ID22876A (es) |
| IL (1) | IL133036A0 (es) |
| MA (1) | MA26501A1 (es) |
| NO (1) | NO995711L (es) |
| OA (1) | OA11515A (es) |
| PE (1) | PE75199A1 (es) |
| PL (1) | PL336942A1 (es) |
| SK (1) | SK159299A3 (es) |
| TR (1) | TR199902883T2 (es) |
| WO (1) | WO1998052942A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ511777A (en) * | 1998-11-20 | 2003-12-19 | Smithkline Beecham S | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| US6780875B2 (en) * | 1998-11-20 | 2004-08-24 | Smithkline Beecham S.P.A. | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| GB9825554D0 (en) | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
| EP1165542B1 (en) | 1999-03-29 | 2003-08-20 | Neurogen Corporation | 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
| AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
| AU2001276556A1 (en) * | 2000-08-11 | 2002-02-25 | Smithkline Beecham P.L.C. | Novel pharmaceutical use of quinnoline derivatives |
| JP2004517062A (ja) * | 2000-11-13 | 2004-06-10 | グラクソスミスクライン・ソシエタ・ペル・アチオニ | Ｎｋ−３およびｎｋ−２アンタゴニストとしてのキノリン誘導体 |
| EP1351953A1 (en) * | 2000-11-28 | 2003-10-15 | GlaxoSmithKline S.p.A. | Quinoline derivatives as nk-3 antagonists |
| GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
| US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
| ATE313539T1 (de) * | 2001-04-11 | 2006-01-15 | Glaxosmithkline Spa | Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten |
| GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
| MY134211A (en) * | 2001-05-18 | 2007-11-30 | Smithkline Beecham Corp | Novel use |
| GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0425076D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0425075D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| WO2006130080A2 (en) * | 2005-06-03 | 2006-12-07 | Astrazeneca Ab | Quinoline derivatives as nk3 anatgonists |
| GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
| AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
| DE202007017299U1 (de) * | 2007-12-12 | 2009-04-23 | Drebo Werkzeugfabrik Gmbh | Bohrer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2227769T3 (es) * | 1994-05-27 | 2005-04-01 | Glaxosmithkline S.P.A. | Derivados de quinolina como antagonistas del receptor nk3 de taquiquinina. |
| AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
-
1998
- 1998-05-18 AT AT98932069T patent/ATE244711T1/de not_active IP Right Cessation
- 1998-05-18 CN CN98807356A patent/CN1264378A/zh active Pending
- 1998-05-18 WO PCT/EP1998/003014 patent/WO1998052942A1/en not_active Application Discontinuation
- 1998-05-18 SK SK1592-99A patent/SK159299A3/sk unknown
- 1998-05-18 TR TR1999/02883T patent/TR199902883T2/xx unknown
- 1998-05-18 ES ES98932069T patent/ES2201509T3/es not_active Expired - Lifetime
- 1998-05-18 EA EA199901062A patent/EA199901062A1/ru unknown
- 1998-05-18 AP APAP/P/1999/001695A patent/AP9901695A0/en unknown
- 1998-05-18 BR BR9809652-4A patent/BR9809652A/pt not_active IP Right Cessation
- 1998-05-18 JP JP54996798A patent/JP2002500645A/ja not_active Ceased
- 1998-05-18 DE DE69816290T patent/DE69816290T2/de not_active Expired - Fee Related
- 1998-05-18 CA CA002291111A patent/CA2291111A1/en not_active Abandoned
- 1998-05-18 HU HU0002300A patent/HUP0002300A3/hu unknown
- 1998-05-18 EP EP98932069A patent/EP0983262B1/en not_active Expired - Lifetime
- 1998-05-18 PL PL98336942A patent/PL336942A1/xx unknown
- 1998-05-18 AU AU82098/98A patent/AU8209898A/en not_active Abandoned
- 1998-05-18 ID IDW991432A patent/ID22876A/id unknown
- 1998-05-18 IL IL13303698A patent/IL133036A0/xx unknown
- 1998-05-19 DZ DZ980108A patent/DZ2498A1/xx active
- 1998-05-20 PE PE1998000398A patent/PE75199A1/es not_active Application Discontinuation
- 1998-05-21 MA MA25086A patent/MA26501A1/fr unknown
- 1998-05-21 AR ARP980102363A patent/AR012732A1/es not_active Application Discontinuation
- 1998-05-22 CO CO98029024A patent/CO4950515A1/es unknown
-
1999
- 1999-11-22 NO NO995711A patent/NO995711L/no not_active Application Discontinuation
- 1999-11-23 OA OA9900253A patent/OA11515A/en unknown
- 1999-12-14 BG BG104009A patent/BG104009A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002500645A (ja) | 2002-01-08 |
| PE75199A1 (es) | 1999-10-22 |
| CO4950515A1 (es) | 2000-09-01 |
| EA199901062A1 (ru) | 2000-08-28 |
| IL133036A0 (en) | 2001-03-19 |
| HUP0002300A2 (hu) | 2001-06-28 |
| PL336942A1 (en) | 2000-07-17 |
| TR199902883T2 (xx) | 2000-05-22 |
| DE69816290T2 (de) | 2004-05-27 |
| NO995711D0 (no) | 1999-11-22 |
| CN1264378A (zh) | 2000-08-23 |
| OA11515A (en) | 2004-02-04 |
| DE69816290D1 (de) | 2003-08-14 |
| WO1998052942A1 (en) | 1998-11-26 |
| MA26501A1 (fr) | 2004-12-20 |
| BG104009A (en) | 2000-07-31 |
| DZ2498A1 (fr) | 2003-01-25 |
| ES2201509T3 (es) | 2004-03-16 |
| SK159299A3 (en) | 2000-06-12 |
| AU8209898A (en) | 1998-12-11 |
| BR9809652A (pt) | 2001-09-11 |
| ID22876A (id) | 1999-12-16 |
| CA2291111A1 (en) | 1998-11-26 |
| HUP0002300A3 (en) | 2002-01-28 |
| EP0983262B1 (en) | 2003-07-09 |
| AP9901695A0 (en) | 1999-12-31 |
| EP0983262A1 (en) | 2000-03-08 |
| ATE244711T1 (de) | 2003-07-15 |
| NO995711L (no) | 2000-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012732A1 (es) | Derivados de fenilquinolinas, procedimientos para su preparacion, composiciones farmaceuticas, y su uso para la fabricacion de medicamentos | |
| AR021354A1 (es) | Procedimiento para la preparacion de un compuesto derivado de quinolina y un procedimiento para preparar una composicion farmaceutica | |
| ES2192588T3 (es) | 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas. | |
| AR004219A1 (es) | Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios | |
| RU2000128033A (ru) | Гетероциклические производные глицил-бета-аланина в качестве антагонистов витронектина | |
| UY26727A1 (es) | Derivados de tropano útiles en terapia | |
| DK1392714T3 (da) | Steroider som agonister for FXR | |
| CL2004000382A1 (es) | Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6. | |
| EA200400054A1 (ru) | Замещенные нафтилиндольные производные в качестве ингибиторов ингибитора активатора плазминогена типа 1 (pai-1) | |
| CO5280059A1 (es) | Derivados de 2-ox-1-pirrolidina, procewo para prepararlos y sus aplicaciones | |
| AR033306A1 (es) | Compuestos | |
| PE20040907A1 (es) | Derivados de anilinopirazol | |
| AR007030A1 (es) | Un compuesto derivado de indol, su uso, un procedimiento para producirlo, y una composicion farmaceutica que lo contiene | |
| AR004706A1 (es) | Un compuesto derivado de benzoxazina y pirido-oxazina utiles como antimicrobianos, composicion farmaceutica que lo contienen, un metodo para preparar dichos compuestos e intermediarios utiles para dicho metodo. | |
| UY27338A1 (es) | Nuevos derivados de ácido sulfónico | |
| CO5680413A2 (es) | Aminoacidos con afinidad por la proteina c2 delta | |
| AR036864A1 (es) | Uso de compuestos de acido benzacepin-n-acetico, y procedimiento para la preparacion de dichos compuestos | |
| AR057961A1 (es) | Derivados de pirrolopirimidinas con actividad inhibitoria de receptor de tirosina quinasa. composiciones farmaceuticas. | |
| AR041340A1 (es) | Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen | |
| AR035110A1 (es) | Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto | |
| DE60330758D1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| AR044453A1 (es) | Derivados de metoxi-pirazin-tienil sulfonamida | |
| AR015445A1 (es) | Metodo para preparar un compuesto derivado de quinolina, dichos compuestos y compuestos intermediarios | |
| DK0902684T3 (da) | Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler | |
| PE20021003A1 (es) | Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |